Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

TBP

Tetra Bio Pharma (TBP)

Tetra Bio Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:TSX:TBP
DateTimeSourceHeadlineSymbolCompany
03/07/20238:01AMPR Newswire (Canada)Suspension de la négociation par l'OCRCVM - TBPTSX:TBPTetra Bio Pharma Inc
03/07/20237:59AMPR Newswire (Canada)IIROC Trading Halt - TBPTSX:TBPTetra Bio Pharma Inc
02/10/20236:27PMPR Newswire (Canada)Tetra Bio-Pharma Announces Listing to OTCPink MarketTSX:TBPTetra Bio Pharma Inc
02/10/20236:27PMPR Newswire (US)Tetra Bio-Pharma Announces Listing to OTCPink MarketTSX:TBPTetra Bio Pharma Inc
12/22/20227:41AMPR Newswire (Canada)REDUVO™ Marketing Approval on the Right PathTSX:TBPTetra Bio Pharma Inc
12/22/20227:41AMPR Newswire (US)REDUVO™ Marketing Approval on the Right PathTSX:TBPTetra Bio Pharma Inc
12/06/20227:00AMPR Newswire (US)Tetra Bio-Pharma Announces Results of Artificial Intelligence Study of ARDS-003 Combined with FavipiravirTSX:TBPTetra Bio Pharma Inc
12/06/20227:00AMPR Newswire (Canada)Tetra Bio-Pharma Announces Results of Artificial Intelligence Study of ARDS-003 Combined with FavipiravirTSX:TBPTetra Bio Pharma Inc
11/29/20227:00AMPR Newswire (US)Tetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003TSX:TBPTetra Bio Pharma Inc
11/29/20227:00AMPR Newswire (Canada)Tetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003TSX:TBPTetra Bio Pharma Inc
11/18/202212:23PMPR Newswire (Canada)Tetra Bio-Pharma Provides Update on Its REDUVO™ New Drug SubmissionTSX:TBPTetra Bio Pharma Inc
11/18/202212:23PMPR Newswire (US)Tetra Bio-Pharma Provides Update on Its REDUVO™ New Drug SubmissionTSX:TBPTetra Bio Pharma Inc
10/27/20221:57PMPR Newswire (US)Tetra Bio-Pharma Inc. Announces Second Closing of Financing with Alpha Blue OceanTSX:TBPTetra Bio Pharma Inc
10/27/20221:57PMPR Newswire (Canada)Tetra Bio-Pharma Inc. Announces Second Closing of Financing with Alpha Blue OceanTSX:TBPTetra Bio Pharma Inc
10/11/20227:42AMPR Newswire (US)Tetra and Prepaire Jointly Apply to BARDA for FundingTSX:TBPTetra Bio Pharma Inc
10/11/20227:42AMPR Newswire (Canada)Tetra and Prepaire Jointly Apply to BARDA for FundingTSX:TBPTetra Bio Pharma Inc
09/08/20227:44AMPR Newswire (Canada)Tetra Bio-Pharma Inc. Announces Revised Terms and First Closing of Financing with Alpha Blue OceanTSX:TBPTetra Bio Pharma Inc
09/08/20227:44AMPR Newswire (US)Tetra Bio-Pharma Inc. Announces Revised Terms and First Closing of Financing with Alpha Blue OceanTSX:TBPTetra Bio Pharma Inc
09/06/20229:28AMPR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - TBPTSX:TBPTetra Bio Pharma Inc
09/06/20229:27AMPR Newswire (Canada)IIROC Trade Resumption - TBPTSX:TBPTetra Bio Pharma Inc
09/06/20229:13AMPR Newswire (Canada)Tetra Collaborates with Cellvera to Develop a Potential Oral Combination Treatment for COVID-19 PatientsTSX:TBPTetra Bio Pharma Inc
09/06/20229:13AMPR Newswire (US)Tetra Collaborates with Cellvera to Develop a Potential Oral Combination Treatment for COVID-19 PatientsTSX:TBPTetra Bio Pharma Inc
09/06/20228:43AMPR Newswire (Canada)Suspension de la négociation par l'OCRCVM - TBPTSX:TBPTetra Bio Pharma Inc
09/06/20228:41AMPR Newswire (Canada)IIROC Trading Halt - TBPTSX:TBPTetra Bio Pharma Inc
08/11/202210:19PMPR Newswire (US)Tetra Bio-Pharma Inc. Secures $6,000,000 Financing from Alpha Blue OceanTSX:TBPTetra Bio Pharma Inc
08/11/202210:19PMPR Newswire (Canada)Tetra Bio-Pharma Inc. Secures $6,000,000 Financing from Alpha Blue OceanTSX:TBPTetra Bio Pharma Inc
08/10/20226:30AMPR Newswire (Canada)Tetra Bio-Pharma Announces Positive Preclinical Results of ARDS-003, a Novel Therapeutic for Sepsis and Viral InfectionsTSX:TBPTetra Bio Pharma Inc
08/10/20226:30AMPR Newswire (US)Tetra Bio-Pharma Announces Positive Preclinical Results of ARDS-003, a Novel Therapeutic for Sepsis and Viral InfectionsTSX:TBPTetra Bio Pharma Inc
07/12/20227:30AMPR Newswire (Canada)Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription DrugTSX:TBPTetra Bio Pharma Inc
07/12/20227:30AMPR Newswire (US)Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription DrugTSX:TBPTetra Bio Pharma Inc
 Showing the most relevant articles for your search:TSX:TBP

Your Recent History

Delayed Upgrade Clock